Emerging Biotech Sector in Malaysia
Single User PDF Format: US$ 1,100.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00
Malaysia has effectively witnessed an upsurge in the profitability and development of the domestic biotechnology industry. Malaysian biotech market has been growing at the double digit rate for the past few years on the back of factors, such as rich biodiversity, active participation by the government and private players, high investments, and technological up-gradation. According to our new research report “Emerging Biotech Sector in Malaysia”, the biotech market in Malaysia reached to the mark of RM 663 Million (US$ 212 Million) in 2010 and is likely to grow at the CAGR of around 16% to reach RM 885 Million (US$ 283 Million) by 2012.
We have covered the key segments of biotechnology industry in Malaysia namely healthcare biotech, agriculture biotech, and industrial biotech. These segments are the focus areas of both the government and private market players. Under National Biotechnology Program, the authorities have extensively planned out various strategies and goals regarding each of these segments and positive developments are likely to boost revenue patterns in future.
Our report has found that agricultural biotechnology holds immense growth potential mainly due to the fact that new innovations and technological up-gradations are providing numerous advantages to this area. Marine biotechnology and crop-related biotechnology are being considered as the future growth areas. In the healthcare biotechnology segments, there are various sub-segments that are likely to witness high investments, such as contract manufacturing, CRO, drug discovery among others. The country offers a supportive environment for the global healthcare and pharmaceutical companies to build their operation. Besides, ‘BioNexus’ status provides many benefits to biotech companies.
Overall, the report analyzes all the key aspects of the Malaysian biotech industry and studies current trends and their impacts on different segments of the industry. The report also provides statistical data and an effective analysis of the macroeconomic factors, market restraints, and challenges. It also describes the role of government and regulatory mechanisms concerning industry and covers key industry players that will help clients to plan market strategies and assess areas of opportunity in the Malaysian biotech market.
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00
Malaysia has effectively witnessed an upsurge in the profitability and development of the domestic biotechnology industry. Malaysian biotech market has been growing at the double digit rate for the past few years on the back of factors, such as rich biodiversity, active participation by the government and private players, high investments, and technological up-gradation. According to our new research report “Emerging Biotech Sector in Malaysia”, the biotech market in Malaysia reached to the mark of RM 663 Million (US$ 212 Million) in 2010 and is likely to grow at the CAGR of around 16% to reach RM 885 Million (US$ 283 Million) by 2012.
We have covered the key segments of biotechnology industry in Malaysia namely healthcare biotech, agriculture biotech, and industrial biotech. These segments are the focus areas of both the government and private market players. Under National Biotechnology Program, the authorities have extensively planned out various strategies and goals regarding each of these segments and positive developments are likely to boost revenue patterns in future.
Our report has found that agricultural biotechnology holds immense growth potential mainly due to the fact that new innovations and technological up-gradations are providing numerous advantages to this area. Marine biotechnology and crop-related biotechnology are being considered as the future growth areas. In the healthcare biotechnology segments, there are various sub-segments that are likely to witness high investments, such as contract manufacturing, CRO, drug discovery among others. The country offers a supportive environment for the global healthcare and pharmaceutical companies to build their operation. Besides, ‘BioNexus’ status provides many benefits to biotech companies.
Overall, the report analyzes all the key aspects of the Malaysian biotech industry and studies current trends and their impacts on different segments of the industry. The report also provides statistical data and an effective analysis of the macroeconomic factors, market restraints, and challenges. It also describes the role of government and regulatory mechanisms concerning industry and covers key industry players that will help clients to plan market strategies and assess areas of opportunity in the Malaysian biotech market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. KEY MARKET TRENDS AND DRIVERS
3.1 Rich Biodiversity
3.2 Low Cost Manufacturing
3.3 Biotech Education Infrastructure
4. BIOTECHNOLOGY INDUSTRY
4.1 Market Overview
4.2 Investment Scenario
4.3 BioNexus Status
5. MARKET SEGMENTS
5.1 Healthcare Biotechnology
5.1.1 Pharmaceutical
5.1.2 Clinical Research Industry
5.1.3 Medical Devices
5.1.4 Contract Manufacturing
5.1.5 Drugs Research & Development
5.2 Agricultural Biotechnology
5.2.1 Crop-related Biotechnology
5.2.2 Livestock Biotechnology
5.2.3 Marine/Aquaculture Biotechnology
5.2.4 Natural Products
5.3 Industrial Biotechnology
5.3.1 Biofuel
5.3.2 Biocatalysts
5.3.3 Fine & Speciality Chemicals
6. REGULATORY CLIMATE
7. INDUSTRY ROADBLOCKS
7.1 Lack of Human Resources
7.2 Insufficient Funding
7.3 Distribution Network
7.4 Dependency on Import for Raw Materials
8. COMPETITIVE LANDSCAPE
8.1 Foreign Players
8.1.1 Astellas Pharma Inc
8.1.2 Saamya Biotech Ltd
8.1.3 Psimei Pharmaceuticals plc
8.1.4 Simugen Asia Sdn Bhd
8.1.5 Siogen Biotech Sdn Bhd
8.2 Domestic Players
8.2.1 Bio-Collagen Technologies Sdn Bhd
8.2.2 BioMolecular Industries Sdn Bhd
8.2.3 DNA Laboratories Malaysia Sdn Bhd
8.2.4 Bioven Sdn Bhd
2. RESEARCH METHODOLOGY
3. KEY MARKET TRENDS AND DRIVERS
3.1 Rich Biodiversity
3.2 Low Cost Manufacturing
3.3 Biotech Education Infrastructure
4. BIOTECHNOLOGY INDUSTRY
4.1 Market Overview
4.2 Investment Scenario
4.3 BioNexus Status
5. MARKET SEGMENTS
5.1 Healthcare Biotechnology
5.1.1 Pharmaceutical
5.1.2 Clinical Research Industry
5.1.3 Medical Devices
5.1.4 Contract Manufacturing
5.1.5 Drugs Research & Development
5.2 Agricultural Biotechnology
5.2.1 Crop-related Biotechnology
5.2.2 Livestock Biotechnology
5.2.3 Marine/Aquaculture Biotechnology
5.2.4 Natural Products
5.3 Industrial Biotechnology
5.3.1 Biofuel
5.3.2 Biocatalysts
5.3.3 Fine & Speciality Chemicals
6. REGULATORY CLIMATE
7. INDUSTRY ROADBLOCKS
7.1 Lack of Human Resources
7.2 Insufficient Funding
7.3 Distribution Network
7.4 Dependency on Import for Raw Materials
8. COMPETITIVE LANDSCAPE
8.1 Foreign Players
8.1.1 Astellas Pharma Inc
8.1.2 Saamya Biotech Ltd
8.1.3 Psimei Pharmaceuticals plc
8.1.4 Simugen Asia Sdn Bhd
8.1.5 Siogen Biotech Sdn Bhd
8.2 Domestic Players
8.2.1 Bio-Collagen Technologies Sdn Bhd
8.2.2 BioMolecular Industries Sdn Bhd
8.2.3 DNA Laboratories Malaysia Sdn Bhd
8.2.4 Bioven Sdn Bhd
LIST OF FIGURES:
Figure 3-1: Educational Institutions Offering Degree in Biotechnology
Figure 3-2: Educational Institutions Offering Master’s Degree in Biotechnology
Figure 3-3: Educational Institutions Offering PhD in Biotechnology
Figure 4-1: Biotechnology Market (Million RM), 2008-2012
Figure 4-2: Biotech Sector Contribution to GDP (%), 2010, 2015 & 2020
Figure 4-3: Investment in Biotechnology Market by Segment (%), 2009
Figure 4-4: Venture Capital Investment in Biotech & Life Sciences Sector (Million US$), 2007-2009
Figure 4-5: R&D Spending in Biotech Sector (Million RM), 2008-2010
Figure 5-1: Healthcare Biotechnology Market (Million RM), 2008-2012
Figure 5-2: Healthcare Biotech Companies by Segment (%)
Figure 5-3: Herbal Industry (Billion US$), 2009-2012
Figure 5-4: Pharmaceutical Market (Million US$), 2009-2012
Figure 5-5: CRO Market (Million RM), 2009-2012
Figure 5-6: Domestic Medical Device Market (Million US$), 2009, 2010 & 2012
Figure 5-7: Spending on R&D by Domestic Medical Industry (Million RM), 2008 & 2009
Figure 5-8: Agricultural Biotechnology Market (Million RM), 2008-2012
Figure 5-9: Animal Health Products & Feed Additives Market (Million US$), 2010
Figure 5-10: Industrial Biotechnology Market (Million RM), 2008-2012
Figure 5-11: Second Generation Biofuel Market (Million US$), 2008 & 2013
Figure 3-1: Educational Institutions Offering Degree in Biotechnology
Figure 3-2: Educational Institutions Offering Master’s Degree in Biotechnology
Figure 3-3: Educational Institutions Offering PhD in Biotechnology
Figure 4-1: Biotechnology Market (Million RM), 2008-2012
Figure 4-2: Biotech Sector Contribution to GDP (%), 2010, 2015 & 2020
Figure 4-3: Investment in Biotechnology Market by Segment (%), 2009
Figure 4-4: Venture Capital Investment in Biotech & Life Sciences Sector (Million US$), 2007-2009
Figure 4-5: R&D Spending in Biotech Sector (Million RM), 2008-2010
Figure 5-1: Healthcare Biotechnology Market (Million RM), 2008-2012
Figure 5-2: Healthcare Biotech Companies by Segment (%)
Figure 5-3: Herbal Industry (Billion US$), 2009-2012
Figure 5-4: Pharmaceutical Market (Million US$), 2009-2012
Figure 5-5: CRO Market (Million RM), 2009-2012
Figure 5-6: Domestic Medical Device Market (Million US$), 2009, 2010 & 2012
Figure 5-7: Spending on R&D by Domestic Medical Industry (Million RM), 2008 & 2009
Figure 5-8: Agricultural Biotechnology Market (Million RM), 2008-2012
Figure 5-9: Animal Health Products & Feed Additives Market (Million US$), 2010
Figure 5-10: Industrial Biotechnology Market (Million RM), 2008-2012
Figure 5-11: Second Generation Biofuel Market (Million US$), 2008 & 2013
LIST OF TABLES:
Table 3-1: Some Newly Discovered Floras and their Therapeutic Uses
Table 3-2: Enrolments in Key Courses (Number), 2007-08 & 2008-09
Table 3-3: Comparison of Factors Affecting Biotechnology Industry among Different Countries
Table 4-1: Drivers for Biotech Industry
Table 4-2: Government & Private Sector Investment in Biotech Industry (Million US$), 2005 to 2009
Table 4-3: Growth in the Number of BioNexus Companies by Sector (2006-2009)
Table 4-4: Number of BioNexus Companies by State (2009)
Table 5-1: Number of Patent Applications by Segment (2004 to 2008)
Table 5-2: Some Major Healthcare Biotechnology Companies
Table 5-3: CRO Industry Statistics (2008, 2009 & 2014)
Table 5-4: Key Trends in Drug Discovery & Delivery
Table 5-5: Key Agriculture Production (‘000 Metric Tons), 2007 & 2010
Table 5-6: Overview of BioNexus Status Companies in Agricultural Biotechnology
Table 5-7: Local and Foreign Patents Applied & Granted in Agricultural Biotechnology (Number), 2007 & 2008
Table 5-8: Some Major Agricultural Biotechnology Companies
Table 5-9: Some Local and International Collaboration in Agricultural Biotechnology (2009)
Table 5-10: Crop-related Biotechnology Applications
Table 5-11: Approved GM Products for Imports
Table 5-12: Local and Foreign Patents Applied & Granted in Industrial Biotechnology (Number), 2007 & 2008
Table 5-13: Biodiesel Production and Export (‘000 Metric Tons), 2007-2011
Table 5-14: Bio-catalysts Isolated from Micro-organisms
Table 5-15: Research Projects in Industrial Biotechnology
Table 5-16: Progress Specific to Industrial Biotechnology
Table 6-1: The Nine Thrusts of the National Biotechnology Policy (NBP)
Table 6-2: Key Highlights of Phase-I under NBP
Table 6-3: Key Highlights of Phase-II under NBP
Table 6-4: Key Highlights of Phase-III under NBP
Table 6-5: Key Goals under National Biotech Policy (2006 to 2020)
Table 3-1: Some Newly Discovered Floras and their Therapeutic Uses
Table 3-2: Enrolments in Key Courses (Number), 2007-08 & 2008-09
Table 3-3: Comparison of Factors Affecting Biotechnology Industry among Different Countries
Table 4-1: Drivers for Biotech Industry
Table 4-2: Government & Private Sector Investment in Biotech Industry (Million US$), 2005 to 2009
Table 4-3: Growth in the Number of BioNexus Companies by Sector (2006-2009)
Table 4-4: Number of BioNexus Companies by State (2009)
Table 5-1: Number of Patent Applications by Segment (2004 to 2008)
Table 5-2: Some Major Healthcare Biotechnology Companies
Table 5-3: CRO Industry Statistics (2008, 2009 & 2014)
Table 5-4: Key Trends in Drug Discovery & Delivery
Table 5-5: Key Agriculture Production (‘000 Metric Tons), 2007 & 2010
Table 5-6: Overview of BioNexus Status Companies in Agricultural Biotechnology
Table 5-7: Local and Foreign Patents Applied & Granted in Agricultural Biotechnology (Number), 2007 & 2008
Table 5-8: Some Major Agricultural Biotechnology Companies
Table 5-9: Some Local and International Collaboration in Agricultural Biotechnology (2009)
Table 5-10: Crop-related Biotechnology Applications
Table 5-11: Approved GM Products for Imports
Table 5-12: Local and Foreign Patents Applied & Granted in Industrial Biotechnology (Number), 2007 & 2008
Table 5-13: Biodiesel Production and Export (‘000 Metric Tons), 2007-2011
Table 5-14: Bio-catalysts Isolated from Micro-organisms
Table 5-15: Research Projects in Industrial Biotechnology
Table 5-16: Progress Specific to Industrial Biotechnology
Table 6-1: The Nine Thrusts of the National Biotechnology Policy (NBP)
Table 6-2: Key Highlights of Phase-I under NBP
Table 6-3: Key Highlights of Phase-II under NBP
Table 6-4: Key Highlights of Phase-III under NBP
Table 6-5: Key Goals under National Biotech Policy (2006 to 2020)
